Market News

Latest financial and economic news and analysis

Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
CrowdStrike Holdings (CRWD) Suffers a Larger Drop Than the General Market: Key Insights

CrowdStrike Holdings (CRWD) Suffers a Larger Drop Than the General Market: Key Insights

In the closing of the recent trading day, CrowdStrike Holdings (CRWD) stood at $207.45, denoting a -1.15% move from the preceding trading day.

Related Symbols 1
CRWD CRWD
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
The Trade Desk (TTD) Misses Q2 Earnings and Revenue Estimates

The Trade Desk (TTD) Misses Q2 Earnings and Revenue Estimates

The Trade Desk (TTD) came out with quarterly earnings of $0.34 per share, missing the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.41 per share a year ago.

Related Symbols 1
TTD TTD
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates

Arcturus Therapeutics (ARCT) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to a loss of $0.34 per share a year ago.

Related Symbols 1
ARCT ARCT
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
Doximity (DOCS) Q1 Earnings Lag Estimates

Doximity (DOCS) Q1 Earnings Lag Estimates

Doximity (DOCS) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.36 per share a year ago.

Related Symbols 1
DOCS DOCS
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
Airbnb, Inc. (ABNB) Beats Q2 Earnings and Revenue Estimates

Airbnb, Inc. (ABNB) Beats Q2 Earnings and Revenue Estimates

Airbnb, Inc. (ABNB) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.2 per share. This compares to earnings of $1.03 per share a year ago.

Related Symbols 1
ABNB ABNB
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates

Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates

Halozyme Therapeutics (HALO) came out with quarterly earnings of $2.28 per share, beating the Zacks Consensus Estimate of $1.82 per share. This compares to earnings of $1.54 per share a year ago.

Related Symbols 1
HALO HALO
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates

Janux Therapeutics, Inc. (JANX) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.55 per share a year ago.

Related Symbols 1
JANX JANX
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to earnings of $0.12 per share a year ago.

Related Symbols 1
QDEL QDEL
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates

Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates

Gen Digital (GEN) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.64 per share a year ago.

Related Symbols 1
GEN GEN
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Proactive Investors News Agency
Yesterday•Proactive Investors
Stocks Medium Importance Neutral
UBS cuts Ocado target by a third as growth path stays clouded

UBS cuts Ocado target by a third as growth path stays clouded

UBS has cut its price target on Ocado Group PLC (LSE:OCDO) to 230p from 340p, a 34% reduction that reflects less confidence in the timing and scale of new contract wins rather than any change to its neutral rating. The shares closed at 212p on Wednesday, leaving barely 9% of implied upside.

Related Symbols 1
UBS UBS
Source: Proactive Investors
Visit Source
0 0 0
Read More
Comment